426 related articles for article (PubMed ID: 27197918)
1. Chemotherapy-related cognitive impairment in older patients with cancer.
Loh KP; Janelsins MC; Mohile SG; Holmes HM; Hsu T; Inouye SK; Karuturi MS; Kimmick GG; Lichtman SM; Magnuson A; Whitehead MI; Wong ML; Ahles TA
J Geriatr Oncol; 2016 Jul; 7(4):270-80. PubMed ID: 27197918
[TBL] [Abstract][Full Text] [Related]
2. Chemotherapy-related cognitive impairment: mechanisms, clinical features and research perspectives.
Cascella M; Di Napoli R; Carbone D; Cuomo GF; Bimonte S; Muzio MR
Recenti Prog Med; 2018 Nov; 109(11):523-530. PubMed ID: 30565571
[TBL] [Abstract][Full Text] [Related]
3. Cognitive Effects of Chemotherapy and Cancer-Related Treatments in Older Adults.
Vega JN; Dumas J; Newhouse PA
Am J Geriatr Psychiatry; 2017 Dec; 25(12):1415-1426. PubMed ID: 28495470
[TBL] [Abstract][Full Text] [Related]
4. Cancer-related cognitive impairment: an update on state of the art, detection, and management strategies in cancer survivors.
Lange M; Joly F; Vardy J; Ahles T; Dubois M; Tron L; Winocur G; De Ruiter MB; Castel H
Ann Oncol; 2019 Dec; 30(12):1925-1940. PubMed ID: 31617564
[TBL] [Abstract][Full Text] [Related]
5. [An overview of the research of cancer-related cognitive impairment].
Ferencz V; S Nagy Z; Tóth M
Orv Hetil; 2019 Sep; 160(38):1495-1502. PubMed ID: 31537098
[TBL] [Abstract][Full Text] [Related]
6. [Chemotherapy-related Cognitive Impairment in Patients with Hodgkin Lymphoma - Pathophysiology and Risk Factors].
Fayette D; Gahérová Ľ; Móciková H; Marková J; Kozák T; Horáček J
Klin Onkol; 2017; 30(2):93-99. PubMed ID: 28397504
[TBL] [Abstract][Full Text] [Related]
7. Clinical characteristics, pathophysiology, and management of noncentral nervous system cancer-related cognitive impairment in adults.
Wefel JS; Kesler SR; Noll KR; Schagen SB
CA Cancer J Clin; 2015 Mar; 65(2):123-38. PubMed ID: 25483452
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms and Treatment for Cancer- and Chemotherapy-Related Cognitive Impairment in Survivors of Non-CNS Malignancies.
Chung NC; Walker AK; Dhillon HM; Vardy JL
Oncology (Williston Park); 2018 Dec; 32(12):591-8. PubMed ID: 30632128
[TBL] [Abstract][Full Text] [Related]
9. The Experience of Cancer-Related Cognitive Impairment Across Common Cancers: Protocol for a Qualitative Systematic Review.
Ibrar M; Rai HK; Main A; McCartney H; Maguire R; Rodriguez MAP
JMIR Res Protoc; 2024 May; 13():e56888. PubMed ID: 38820581
[TBL] [Abstract][Full Text] [Related]
10. Replication and Meta-analysis of the Association between BDNF Val66Met Polymorphism and Cognitive Impairment in Patients Receiving Chemotherapy.
Tan CJ; Lim SWT; Toh YL; Ng T; Yeo A; Shwe M; Foo KM; Chu P; Jain A; Koo SL; Dent RA; Ng RCH; Yap YS; Lim EH; Loh KW; Chay WY; Lee GE; Tan TJY; Beh SY; Wong M; Chan JJ; Khor CC; Ho HK; Chan A
Mol Neurobiol; 2019 Jul; 56(7):4741-4750. PubMed ID: 30382534
[TBL] [Abstract][Full Text] [Related]
11. Effects of Acupuncture on Cancer-Related Cognitive Impairment in Chinese Gynecological Cancer Patients: A Pilot Cohort Study.
Zeng Y; Cheng ASK; Song T; Sheng X; Wang S; Xie J; Chan CCH
Integr Cancer Ther; 2018 Sep; 17(3):737-746. PubMed ID: 29806502
[TBL] [Abstract][Full Text] [Related]
12. The Effect of Exercise on Cancer-Related Cognitive Impairment and Applications for Physical Therapy: Systematic Review of Randomized Controlled Trials.
Campbell KL; Zadravec K; Bland KA; Chesley E; Wolf F; Janelsins MC
Phys Ther; 2020 Mar; 100(3):523-542. PubMed ID: 32065236
[TBL] [Abstract][Full Text] [Related]
13. An Evaluation of the Multifactorial Model of Cancer-Related Cognitive Impairment.
Oppegaard KR; Mayo SJ; Armstrong TS; Kober KM; Anguera JA; Wright F; Levine JD; Conley YP; Paul S; Cooper B; Miaskowski C
Nurs Res; 2023 Jul-Aug 01; 72(4):272-280. PubMed ID: 37104681
[TBL] [Abstract][Full Text] [Related]
14. Cognitive impairment following chemotherapy for breast cancer: The impact of practice effect on results.
Cerulla N; Arcusa À; Navarro JB; de la Osa N; Garolera M; Enero C; Chico G; Fernández-Morales L
J Clin Exp Neuropsychol; 2019 Apr; 41(3):290-299. PubMed ID: 30477390
[TBL] [Abstract][Full Text] [Related]
15. A Drosophila model relevant to chemotherapy-related cognitive impairment.
Torre M; Bukhari H; Nithianandam V; Zanella CA; Mata DA; Feany MB
Sci Rep; 2023 Nov; 13(1):19290. PubMed ID: 37935827
[TBL] [Abstract][Full Text] [Related]
16. What is known and unknown about chemotherapy-related cognitive impairment in patients with haematological malignancies and areas of needed research.
Williams AM; Zent CS; Janelsins MC
Br J Haematol; 2016 Sep; 174(6):835-46. PubMed ID: 27391367
[TBL] [Abstract][Full Text] [Related]
17. Measuring Self-Reported Cancer-Related Cognitive Impairment: Recommendations From the Cancer Neuroscience Initiative Working Group.
Henneghan AM; Van Dyk K; Kaufmann T; Harrison R; Gibbons C; Heijnen C; Kesler SR
J Natl Cancer Inst; 2021 Nov; 113(12):1625-1633. PubMed ID: 33638633
[TBL] [Abstract][Full Text] [Related]
18. Blood-based biomarkers of cancer-related cognitive impairment in non-central nervous system cancer: protocol for a scoping review.
Mayo SJ; Kuruvilla J; Laister RC; Ayala AP; Alm M; Byker W; Kelly DL; Saligan L
BMJ Open; 2018 Jan; 8(1):e017578. PubMed ID: 29374660
[TBL] [Abstract][Full Text] [Related]
19. Cognitive impairment in gynecologic cancers: a systematic review of current approaches to diagnosis and treatment.
Craig CD; Monk BJ; Farley JH; Chase DM
Support Care Cancer; 2014 Jan; 22(1):279-87. PubMed ID: 24212261
[TBL] [Abstract][Full Text] [Related]
20. [Cancer-related Cognitive Impairment: Current Knowledge and Future Challenges].
Tanimukai H
Seishin Shinkeigaku Zasshi; 2015; 117(8):585-600. PubMed ID: 26642725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
